Israel has developed a comprehensive network of diagnostic facilities for cancer care. These centres typically offer advanced imaging technologies such as magnetic resonance imaging (MRI), computed tomography (CT) scans, positron emission tomography (PET) scans, and ultrasound. Many hospitals also provide digital mammography and bone scans. Diagnostic pathology services include immunohistochemistry, genetic profiling, and molecular testing. Such tests help determine the specific type of cancer and its biological characteristics, which in turn guides treatment planning. Biopsies, including core needle and endoscopic procedures, are carried out under image guidance to ensure accuracy. The decision about which diagnostic tests are appropriate rests with the patient's own treating doctor, based on the individual clinical picture.
A notable feature of oncology in Israel is the routine use of multidisciplinary tumour boards. These boards bring together specialists from different fields—medical oncologists, radiation oncologists, surgeons, pathologists, radiologists, and often genetic counsellors and specialist nurses. The team reviews each patient's diagnostic results and discusses treatment options in a collaborative setting. This approach helps to ensure that recommendations are balanced and consider all relevant aspects of the patient's condition. Tumour boards are particularly valuable for complex or rare cancers. Patients referred to an Israeli hospital can expect that their case will be presented to such a board before a final treatment plan is confirmed. Again, the ultimate treatment decisions are made by the patient and their lead clinician.
Surgery remains a cornerstone of cancer treatment in Israel, with many hospitals offering a full range of surgical oncology procedures. These include both open and minimally invasive techniques. Laparoscopic and robotic-assisted surgeries are available for many tumour types, often resulting in shorter recovery times and reduced hospital stays. Surgical teams specialise in procedures for breast cancer, colorectal cancer, lung cancer, gynaecological cancers, urological cancers, and head and neck cancers, among others. Sentinel lymph node biopsy, oncoplastic breast surgery, and liver or lung resections are all standard offerings. Pre-operative assessment and post-operative care follow internationally recognised guidelines. The choice of surgical approach depends on factors such as tumour stage, location, and the patient's overall health, and must be determined by the treating surgeon in consultation with the patient.
Radiotherapy services in Israel include external beam radiotherapy, intensity-modulated radiotherapy (IMRT), stereotactic radiosurgery, and stereotactic body radiotherapy (SBRT). Brachytherapy is also available for certain cancers such as cervical, prostate, and breast cancer. Treatment planning uses detailed imaging and computer modelling to target the tumour while sparing healthy tissue. Systemic therapies encompass a wide spectrum, from conventional chemotherapy to targeted therapies, hormonal treatments, and immunotherapy. Many hospitals now offer oral chemotherapy and biologic agents, which can be taken at home under medical supervision. The selection of a particular drug or combination depends on the cancer type, genetic markers, and the patient's medical history. All treatment decisions should be made by the patient's qualified oncologist, who will weigh the potential benefits and risks.
Israel has a strong tradition of clinical research, and many hospitals participate in national and international clinical trials. These trials may investigate new drugs, combination therapies, novel radiotherapy techniques, or innovative diagnostic methods. Access to clinical trials can provide patients with therapies that are not yet widely available. Eligibility criteria vary, and not every patient will qualify. The decision to enrol in a trial is voluntary and requires a full discussion with the treating doctor about the aims, procedures, and possible outcomes. Patients considering medical travel for an oncology trial should verify the trial's status and suitability with their own physician and the trial's principal investigator. No promises of success can be made, and participation does not guarantee a cure.
Supportive care is integrated into oncology services in Israel to help manage symptoms and side effects of cancer and its treatment. This includes pain management, nutritional support, physiotherapy, psychological counselling, and social work services. Palliative care teams work alongside oncologists to improve quality of life for patients with advanced disease. Services such as nausea control, fatigue management, and wound care are standard. Many hospitals also offer complementary therapies like art therapy, music therapy, and guided relaxation as part of a holistic approach. Support groups and patient education programmes are available. While the medical team can provide information and recommendations, the patient and their family should discuss all supportive care decisions with the doctor managing the overall treatment.
This page provides general information about oncology services available in Israel. It is not a substitute for professional medical advice. Every patient's situation is unique. Diagnosis and treatment decisions must be made by a qualified doctor who knows the patient's full medical history and current condition. Patients should consult their own healthcare provider before making any decisions about cancer care or medical travel.